EuBiologics Co.,Ltd

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

Role: lead

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Role: lead

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

Role: collaborator

A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older

Role: lead

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Role: lead

Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old

Role: lead

Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™

Role: collaborator

Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

Role: lead

Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines

Role: lead

Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants

Role: lead

Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old

Role: lead

Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

Role: lead

Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects

Role: lead

Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults

Role: lead

Safety and Immunogenicity of a New Formulation of Euvichol®

Role: collaborator

To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children

Role: lead

To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men

Role: lead